CryoLogyx

 

CryoLogyx. Founded by Dr. Tom Congdon and Prof. Matt Gibson, CryoLogyx specializes in developing high-quality cryopreservation solutions for cell-based assays in drug discovery. Here are some key points about CryoLogyx:

  • PlateReady™: Cryopreserved cells directly adhered to microplates, ready for assays within 24 hours post-thaw.

  • CryoShield™: Their patented cryopreservation formulation integrates nature-inspired soluble ice nucleators, controlling ice nucleation and mitigating supercooling effects.

  • CustomReady™: Customized cell-banking service tailored to meet specific research needs, ensuring ready-to-use, high-quality cells.

  • Achievements: CryoLogyx has received awards, including the SLAS Europe New Product Award in 2024.

Discover CryoLogyx’s advanced cryopreservation solutions – simply thaw with cell culture medium, and the cells are ready for use within 24 hours post-thaw. If you have any more questions or need further information, feel free to contact us.

 

Learn more:

  

 

 

 

         

Assay Ready Cryopreservation of Hepatocytes

as 2-D Monolayers

 

           

Meet CryoShield™ : Multi Award-winning

Cryopreservation Solutions

 

            

Meet our latest cryopreserved

 

 

 

 

         
PlaqueReadyTM Models    PlateReady™ Assay-Ready Plates   ToxReady TM Plates
       

 

 

 

Watch the videos :

 

 
 

Thaw and Use Master Class 24 Well Edition

 

       

Thaw and Use Master Class - 96 Well Edition

 

       

How to use CryoLogyx Thaw and Test Assay Cells 

 

         

 

website: www.cryologyx.com

 
Other cancers

Other cancers

Cancers or cell lines derived from unusual sites represent a distinctive category in medical research, exploring unconventional anatomical locations to study the biology of cancer. These types of cancers may emerge from rare tissues or unusual anatomical sites, offering unique insights into the mechanisms underlying malignancy.

By examining these unusual cancers, research can reveal crucial information about genetic variability, altered signalling pathways and potential therapeutic targets.

In addition, the study of cancer cells from atypical sites may have significant implications for the development of new diagnostic and therapeutic approaches. Understanding how these cancers behave and respond to treatment may pave the way for more effective personalised strategies.

In summary, cancers or cell lines derived from unusual sites play an essential role in cancer research, offering unique insights that broaden our understanding of the disease and pave the way for innovative advances in oncology.

Resultados de su búsqueda : 1 Producto encontrado

Refine su búsqueda :

RUOCE / IVD
  • Cell line 1
APLICAR FILTROS
REINICIE


Referencia
Descripción
Cond.
Precio Sin IVA